GHELARDINI, CARLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 40.187
NA - Nord America 31.435
AS - Asia 4.701
AF - Africa 198
SA - Sud America 17
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 76.555
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 31.337
PL - Polonia 24.687
RU - Federazione Russa 6.533
IE - Irlanda 2.238
IT - Italia 2.222
SE - Svezia 1.748
SG - Singapore 1.257
HK - Hong Kong 1.012
CN - Cina 930
UA - Ucraina 701
DE - Germania 674
FI - Finlandia 530
VN - Vietnam 507
GB - Regno Unito 465
IN - India 426
JO - Giordania 196
TR - Turchia 144
CI - Costa d'Avorio 135
KR - Corea 118
CA - Canada 85
FR - Francia 84
CH - Svizzera 79
BE - Belgio 65
ES - Italia 52
SC - Seychelles 48
NL - Olanda 46
JP - Giappone 44
RO - Romania 15
IR - Iran 14
IL - Israele 9
PK - Pakistan 9
AU - Australia 8
MX - Messico 8
TW - Taiwan 8
AT - Austria 6
BR - Brasile 6
EG - Egitto 6
EU - Europa 6
CZ - Repubblica Ceca 5
AR - Argentina 4
CO - Colombia 4
HR - Croazia 4
LT - Lituania 4
LV - Lettonia 4
NP - Nepal 4
RS - Serbia 4
SA - Arabia Saudita 4
BG - Bulgaria 3
DM - Dominica 3
ID - Indonesia 3
MU - Mauritius 3
PH - Filippine 3
ZA - Sudafrica 3
AM - Armenia 2
DK - Danimarca 2
GR - Grecia 2
LI - Liechtenstein 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BD - Bangladesh 1
BO - Bolivia 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NG - Nigeria 1
PR - Porto Rico 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 76.555
Salva come PNG Salva come JPEG
Città #
Warsaw 24.679
Santa Clara 4.896
Fairfield 4.139
Dublin 2.228
Ashburn 2.193
Chandler 1.956
Woodbridge 1.951
Seattle 1.714
Cambridge 1.642
Houston 1.474
Wilmington 1.426
Jacksonville 1.077
Singapore 948
Altamura 738
Ann Arbor 737
Lawrence 690
Princeton 623
Hong Kong 549
Dong Ket 445
Florence 430
Beijing 375
Mumbai 375
Boston 336
Boardman 329
Medford 308
San Diego 279
Moscow 236
Shanghai 179
Phoenix 172
Buffalo 154
Falls Church 141
Abidjan 135
Izmir 118
New York 112
Helsinki 100
Kent 97
Norwalk 97
Milan 77
Bern 74
Hillsboro 74
Seongnam 73
Los Angeles 69
Rome 65
Brussels 63
London 61
Washington 58
Andover 47
Barcelona 46
West Jordan 46
Toronto 45
Guangzhou 41
Frankfurt Am Main 40
Auburn Hills 39
Yubileyny 38
Dearborn 37
Verona 36
Siena 34
Redwood City 30
Munich 28
Philadelphia 27
Bremen 23
Tokyo 21
Pune 20
Seoul 18
Tappahannock 18
Redmond 17
Central 16
Gavirate 16
Lappeenranta 15
Old Bridge 15
Chicago 14
Kilburn 12
Laurel 12
Ottawa 12
Frankfurt am Main 11
Hangzhou 11
Nanjing 11
Sesto Fiorentino 11
Romola 10
Salerno 10
Castelliri 9
Menlo Park 9
Montréal 9
North Bergen 9
Prato 9
San Jose 9
Shenzhen 9
Bologna 8
Düsseldorf 8
Genoa 8
Islington 8
Mcallen 8
Prescot 8
Saint Louis 8
Arezzo 7
Brooklyn 7
Fuzhou 7
Hanover 7
Las Vegas 7
Naaldwijk 7
Totale 59.680
Salva come PNG Salva come JPEG
Nome #
Antinociceptive property of the nicotinic agonist AG4 in rodents 456
DM235 (sunifiram): a novel nootropic with potential as a cognitive enhancer 360
M1 receptor activation is a requirement for arecoline analgesia. 350
Molecular simplification of 1,4-diazabicyclo[4.3.0]nonan-9-ones gives piperazine derivatives that maintain high nootropic activity 300
AMITRIPTYLINE AND CLOMIPRAMINE ACTIVATE GI-PROTEIN SIGNALING PATHWAY IN THE INDUCTION OF ANALGESIA 291
The novel nootropic compound DM232 (UNIFIRAM) ameliorates memory impairment in mice and rats 290
4-Aminopiperidine derivatives as a new class of potent cognition enhancing drugs 287
Acute effect of Capparis spinosa root extracts on rat articular pain 283
AG-4:A NICOTINIC AGONIST ENDOWED WITH ANTIAMNESIC PROPERTIES 281
Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARc Agonism as Preventive Pharmacological Approach 280
Astragali radix: could it be an adjuvant for oxaliplatin-induced neuropathy? 275
4-methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. 274
A Prolonged Protein Kinase C-Mediated, Opioid-Related Antinociceptive Effect of St John's Wort in Mice 274
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation 271
PIRACETAM AND ANIRACETAM ANTAGONISM OF CENTRALLY ACTIVE DRUG-INDUCED ANTINOCICEPTION 267
HYPOFUNCTIONALITY OF GI PROTEINS AS AETIOPHATOGENETIC MECHANISM FOR MIGRAINE AND CLUSTER HEADACHE 265
Antidepressant phenotype by inhibiting the phospholipase Cβ(1)--protein kinase Cγ pathway in the forced swim test. 265
Contribution of G inhibitory protein alpha subunits in paradoxical hyperalgesia elicited by exceedingly low doses of morphine in mice. 264
Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy 264
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 264
The pharmacological basis of opioids 264
α7 Nicotinic Receptor Promotes the Neuroprotective Functions of Astrocytes against Oxaliplatin Neurotoxicity 264
Anti-neuropathic effects of Rosmarinus officinalis L. terpenoid fraction: Relevance of nicotinic receptors 263
The central analgesia induced by antimigraine drugs is independent from Gi proteins: superiority of a fixed combination of indomethacin, prochlorperazine and caffeine, compared to sumatriptan, in an in vivo model. 262
5-HT1A AGONISTS INDUCE CENTRAL CHOLINERGIC ANTINOCICEPTION 262
Antisense knockdowns of M1 receptors induces transient anterograde amnesia in mice 261
S(-)ET126: a potent and selective M1 antagonist in vitro and in vivo 261
Supraspinal role of protein kinase C in oxaliplatin-induced neuropathy in rat. 259
The Role of TRPA1 and TRPV1 Channels in Orofacial Pain 258
NO DEVELOPMENT OF TOLERANCE TO ANALGESIA BY REPEATED ADMINISTRATION OF H1 ANTAGONISTS 257
3-ALFA-TROPANYL 2-(4-Cl-PHENOXY)BUTIRATE (SM21): A REVIEW OF THE PHARMACOLOGICAL PROFILE OF A NOVEL ENHANCER OF CHOLINERGIC TRANSMISSION. 256
LOCAL ANAESTHETIC ACTIVITY OF (+) AND (-) MENTHOL 256
Design, synthesis and binding affinity of new nicotinic ligands 256
The novel H2S-donor 4-carboxyphenyl isothiocyanate promotes cardioprotective effects against ischemia/reperfusion injury through activation of mitoKATP channels and reduction of oxidative stress 256
A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice. 255
Loss of muscarinic antinociception by antisense inhibition of M1 receptors. 254
Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception. 254
Apoptotic Process Induced by Oxaliplatin in Rat Hippocampus Causes Memory Impairment 254
LOCAL ANAESTHETIC ACTIVITY OF MONOTERPENES AND PHENYLPROPANES OF ESSENTIAL OILS 253
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 253
Acetyl-l-Carnitine in the Management of Pain During Methadone Withdrawal Syndrome. 253
Alpha-2 agonist-induced memory impairment is mediated by the alpha-2A-adrenoceptor subtype. 252
Delay of morphine tolerance by palmitoylethanolamide 251
Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats 250
Prochlorperazine induces central antinociception mediated by the muscarinic system. 249
ROLE OF 5-HT1A RECEPTORS IN A MOUSE PASSIVE AVOIDANCE PARADIGM 248
Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition-enhancers 248
Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: An antisense study. 248
Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8 248
Antihyperalgesic activity of verbascoside in two models of neuropathic pain. 248
Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity 248
Neuroprotective activity of thioctic acid in central nervous system lesions consequent to peripheral nerve injury. 248
EFFECT OF POTASSIUM CHANNEL MODULATORS IN MOUSE FORCED SWIMMING TEST 247
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 247
Role of intracellular calcium in acute thermal pain perception 247
Novel ester and acid derivatives of the 1,5-diarylpyrrole scaffold as anti-inflammatory and analgesic agents. Synthesis and in vitro and in vivo biological evaluation. 247
EFFECT OF PERTUSSIS TOXIN ON BACLOFEN-AND DIPHENHYDRAMINE- INDUCED AMNESIA 246
Central muscarinic antinociception induced by ET-142 and SS-20 in rodents 245
Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice. 245
Memory facilitation with atropine: a paradoxical effect 244
Antihyperalgesic activity of verbascoside in the chronic constriction injury of the sciatic nerve (CCI) and intra-articular injection of sodium monoiodoacetate (MIA) models of neuropatic pain 244
THE ROLE OF POTASSIUM CHANNELS IN ANTIHISTAMINE ANALGESIA 244
ANTINOCICEPTIVE PROFILE OF THE NATURAL CHOLINESTERASE INHIBITOR HUPERZINE A 243
BDNF and ARTEMIN are increased in drug-naïve non-depressed GAD patients: Preliminary data 243
ANTIAMNESIC ACTIVITY OF THE NICOTINIC AGONIST DBO-83 IN MICE 243
Different involvement of type 1, 2, and 3 ryanodine receptors in memory processes. 243
Effect of K+ channel modulation on mouse feeding behaviour 242
Influence of potassium channel modulators on cognitive processes in mice 242
Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice. 242
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 242
Endogenous morphine modulates acute thermonociception in mice. 242
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 242
Pro-cognitive activity induced in the rat by low doses of R-(+)-hyoscyamine. 241
A novel manganese complex effective as superoxide anion scavenger and therapeutic agent against cell and tissue oxidative injury. 241
IMPROVEMENT OF COGNITIVE FUNCTIONS BY THE ACETYLCHOLINE RELEASER SM21 240
Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test. 240
Different apoptotic pathways activated by oxaliplatin in primary astrocytes vs. colo-rectal cancer cells 238
PHARMACOLOGICAL CHARACTERIZATION OF THE NOVEL ACH RELEASER A-TROPANYL 2-(4-BROMOPHENYL)PROPIONATE (PG-9). 238
KV1.1 CHANNEL ANTISENSE ATTENUATES LEARNING AND MODULATION OF DENTATE POLYSIALYLATED NCAM 237
Antineuropathic profile of N-palmitoylethanolamine in a rat model of oxaliplatin-induced neurotoxicity 237
Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. 237
Methylamine and benzylamine induced hypophagia in mice: Modulation by semicarbazide-sensitive benzylamine oxidase inhibitors and aODN towards Kv1.1 channels 237
Involvement of potassium channels in amitriptyline and clomipramine analgesia. 236
Pharmacological in vivo test to evaluate the bioavailability of some St. John’s wort innovative oral preparations 236
An antidepressant behaviour in mice carrying a gene-specific InsP3R1, InsP3R2 and InsP3R3 protein knockdown. 235
Presynaptic Cholinergic Modulators as Potent Cognition Enhancers and Analgesic Drugs. 2. 2-Phenoxy-, 2-(phenylthio)- and 2-(phenylamino)alkanoic Acid Esters 234
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: synthesis, activity, and modeling. 234
Neurotransmitter role of endogenous morphine in CNS. 234
Pharmacological in vivo test to evaluate the bioavailability of some St. John's wort innovative oral preparations 234
Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation 233
ANTIHISTAMINE ANTINOCICEPTION IS MEDIATED BY GI-PROTEIN ACTIVATION 233
Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test. 233
Indomethacin, alone and combined with prochlorperazine and caffeine, but not sumatriptan, abolishes peripheral and central sensitization in in vivo models of migraine. 233
Diphenhydramine-induced amnesia is mediated by Gi-protein activation. 233
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain 233
A REDUCED FUNCTIONALITY OF GI PROTEINS AS A POSSIBLE CAUSE FOR FIBROMYALGIA 232
In vitro characterization of a novel, potent and selective M3 antagonist 232
Ryanodine receptors are involved in muscarinic antinociception in mice. 232
Role of Gi proteins in the antidepressant-like effect of amitriptyline and clomipramine. 232
Aminopyrrolic synthetic receptors for monosaccharides: A class of carbohydrate-binding agents endowed with antibiotic activity versus pathogenic yeasts 232
Totale 25.477
Salva come PNG Salva come JPEG
Categoria #
all - tutte 184.748
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 184.748
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202010.291 0 0 0 0 1.775 1.519 1.357 1.834 1.285 919 1.409 193
2020/202110.618 825 1.120 375 1.313 696 1.189 594 853 892 1.598 351 812
2021/20224.215 115 372 409 161 141 239 172 309 262 302 664 1.069
2022/20239.614 965 1.982 446 565 682 1.674 1.327 527 929 59 290 168
2023/20243.923 172 409 672 187 269 562 162 893 83 201 187 126
2024/202515.154 877 2.741 1.732 3.621 6.183 0 0 0 0 0 0 0
Totale 77.363